/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sonja Zweegman

Dutch Cancer Society(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

766

Papers

32.6K

Citations

87

h-index

319

i10-index

Sonja Zweegman is an academic researcher from Dutch Cancer Society. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Treatment and Pharmacology. The author has an h-index of 87, co-authored 652 publications.

ORCID: 0000-0002-5011-1820

Research Topics

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Cancer Treatment and Pharmacology Peptidase Inhibition and Analysis Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers by this author

works

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

2014 · The Lancet Oncology · 4,761 citations

https://doi.org/10.1016/s1470-2045(14)70442-5

S. Vincent Rajkumar Meletios Α. Dimopoulos Antonio Palumbo Joan Bladé

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

2012 · Journal of Clinical Oncology · 821 citations

https://doi.org/10.1200/jco.2011.39.6820

Pieter Sonneveld Ingo Schmidt‐Wolf Bronno van der Holt Laila el Jarari

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

2017 · The Lancet Oncology · 502 citations

https://doi.org/10.1016/s1470-2045(17)30189-4

Michèle Cavo Evangelos Terpos Cristina Nanni Philippe Moreau

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

2012 · Journal of Clinical Oncology · 444 citations

https://doi.org/10.1200/jco.2012.42.3863

Robyn M. Emanuel Amylou C. Dueck Holly L. Geyer Jean‐Jacques Kiladjian

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

2015 · Haematologica · 391 citations

https://doi.org/10.3324/haematol.2014.117176

Evangelos Terpos Martina Kleber Monika Engelhardt Sonja Zweegman

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

2017 · The Lancet Haematology · 318 citations

https://doi.org/10.1016/s2352-3026(17)30088-1

Claire Harrison Nicolaas Schaap Alessandro M. Vannucchi Jean‐Jacques Kiladjian

Research topics

topics

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Cancer Treatment and Pharmacology

Peptidase Inhibition and Analysis

Myeloproliferative Neoplasms: Diagnosis and Treatment

Chat about Author

Papers

Chat

Click to start Chat